Improving medication adherence in HIV-positive youth using incentives
Goals for Adherence with Low-cost Incentives (GOALS)
This study is looking for ways to help young people with HIV in Uganda stick to their medication by offering small rewards that encourage them to take their medicine regularly, making it easier and more motivating for them to stay healthy.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Rand Corporation NIH-funded |
| Lab location | 1 site (Santa Monica, United States) |
| Project ID | NIH-11036313 on NIH RePORTER |
What this research studies
This research focuses on enhancing medication adherence among HIV-positive youth, particularly in Uganda, by utilizing low-cost incentives informed by behavioral economics. The study aims to address the challenges faced by this vulnerable group, who often struggle with self-control and risk-taking behaviors. By implementing a novel incentive design, the research allows participants with low initial adherence to qualify for rewards, thereby motivating them to improve their medication-taking habits. The approach is based on the understanding that achievable goals can significantly enhance motivation and adherence.
Who could benefit from this research
Good fit: Ideal candidates for this research are HIV-positive youth, particularly those struggling with medication adherence.
Not a fit: Patients who are not HIV-positive or those who have consistently high medication adherence may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved health outcomes for HIV-positive youth by increasing their medication adherence.
How similar studies have performed: Previous studies have shown success in using behavioral economics to improve health behaviors, but this specific approach targeting HIV-positive youth is relatively novel.
Where this research is happening
Santa Monica, United States
- Rand Corporation — Santa Monica, United States (Active)
Researchers
- Principal investigator: Linnemayr, Sebastian — Rand Corporation
- Study coordinator: Linnemayr, Sebastian
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.